- Home
- LEN vs HLN Comparison
LEN vs HLN Comparison
Compare LEN & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEN
- HLN
- Stock Information
- Founded
- LEN 1954
- HLN 2022
- Country
- LEN United States
- HLN United Kingdom
- Employees
- LEN N/A
- HLN N/A
- Industry
- LEN Homebuilding
- HLN Package Goods/Cosmetics
- Sector
- LEN Consumer Discretionary
- HLN Consumer Discretionary
- Exchange
- LEN Nasdaq
- HLN Nasdaq
- Market Cap
- LEN 28.5B
- HLN 48.2B
- IPO Year
- LEN N/A
- HLN N/A
- Fundamental
- Price
- LEN $110.47
- HLN $10.25
- Analyst Decision
- LEN Hold
- HLN Buy
- Analyst Count
- LEN 16
- HLN 1
- Target Price
- LEN $128.13
- HLN $10.95
- AVG Volume (30 Days)
- LEN 3.7M
- HLN 14.1M
- Earning Date
- LEN 06-16-2025
- HLN 07-31-2025
- Dividend Yield
- LEN 1.82%
- HLN 1.73%
- EPS Growth
- LEN N/A
- HLN 38.94
- EPS
- LEN 12.16
- HLN 0.20
- Revenue
- LEN $35,371,977,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- LEN $1.88
- HLN $3.63
- Revenue Next Year
- LEN $4.20
- HLN $4.37
- P/E Ratio
- LEN $9.06
- HLN $25.66
- Revenue Growth
- LEN N/A
- HLN N/A
- 52 Week Low
- LEN $98.42
- HLN $8.37
- 52 Week High
- LEN $187.61
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- LEN 50.29
- HLN 32.60
- Support Level
- LEN $107.87
- HLN $10.19
- Resistance Level
- LEN $118.38
- HLN $10.61
- Average True Range (ATR)
- LEN 3.96
- HLN 0.12
- MACD
- LEN 0.44
- HLN -0.05
- Stochastic Oscillator
- LEN 47.89
- HLN 8.11
About LEN Lennar Corporation
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, active adult, and luxury homebuyers mainly under the Lennar brand name. Lennar's financial services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for-rent construction and has invested in numerous housing-related technology startups.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.